nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—SLC22A11—Methotrexate—urinary bladder cancer	0.137	0.349	CbGbCtD
Doxycycline—CYP3A4—Thiotepa—urinary bladder cancer	0.0827	0.211	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—urinary bladder cancer	0.0797	0.203	CbGbCtD
Doxycycline—SLC22A6—Methotrexate—urinary bladder cancer	0.0555	0.141	CbGbCtD
Doxycycline—CYP3A4—Etoposide—urinary bladder cancer	0.0224	0.0571	CbGbCtD
Doxycycline—MMP7—prostate gland—urinary bladder cancer	0.0174	0.0827	CbGeAlD
Doxycycline—CYP3A4—Doxorubicin—urinary bladder cancer	0.0153	0.0389	CbGbCtD
Doxycycline—SLC22A8—urine—urinary bladder cancer	0.0153	0.0728	CbGeAlD
Doxycycline—MMP7—seminal vesicle—urinary bladder cancer	0.0147	0.07	CbGeAlD
Doxycycline—MMP7—epithelium—urinary bladder cancer	0.0128	0.0608	CbGeAlD
Doxycycline—MMP7—renal system—urinary bladder cancer	0.0118	0.0564	CbGeAlD
Doxycycline—MMP7—urethra—urinary bladder cancer	0.0116	0.0554	CbGeAlD
Doxycycline—MMP1—epithelium—urinary bladder cancer	0.0113	0.0536	CbGeAlD
Doxycycline—MMP1—smooth muscle tissue—urinary bladder cancer	0.0108	0.0517	CbGeAlD
Doxycycline—MMP13—vagina—urinary bladder cancer	0.0108	0.0513	CbGeAlD
Doxycycline—MMP8—female reproductive system—urinary bladder cancer	0.0107	0.0511	CbGeAlD
Doxycycline—MMP1—renal system—urinary bladder cancer	0.0104	0.0498	CbGeAlD
Doxycycline—MMP7—female reproductive system—urinary bladder cancer	0.00947	0.0452	CbGeAlD
Doxycycline—MMP7—vagina—urinary bladder cancer	0.00857	0.0408	CbGeAlD
Doxycycline—MMP1—female reproductive system—urinary bladder cancer	0.00836	0.0399	CbGeAlD
Doxycycline—CYP3A4—urine—urinary bladder cancer	0.00757	0.0361	CbGeAlD
Doxycycline—MMP1—vagina—urinary bladder cancer	0.00756	0.036	CbGeAlD
Doxycycline—SLC22A11—renal system—urinary bladder cancer	0.00662	0.0316	CbGeAlD
Doxycycline—MMP8—lymph node—urinary bladder cancer	0.00627	0.0299	CbGeAlD
Doxycycline—SLC22A8—prostate gland—urinary bladder cancer	0.00548	0.0261	CbGeAlD
Doxycycline—SLC22A11—female reproductive system—urinary bladder cancer	0.0053	0.0253	CbGeAlD
Doxycycline—SLC22A8—renal system—urinary bladder cancer	0.00374	0.0178	CbGeAlD
Doxycycline—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00368	0.00932	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00367	0.00928	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00354	0.00896	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—urinary bladder cancer	0.00337	0.00853	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—IGF1—urinary bladder cancer	0.00327	0.00828	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00318	0.00804	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00306	0.00775	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—FGFR3—urinary bladder cancer	0.00303	0.00766	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00302	0.00763	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—urinary bladder cancer	0.00299	0.00756	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—FGFR3—urinary bladder cancer	0.00285	0.00721	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LOXL4—urinary bladder cancer	0.00283	0.00717	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00278	0.00703	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDK4—urinary bladder cancer	0.00278	0.00703	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00268	0.00679	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—urinary bladder cancer	0.00263	0.00665	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—urinary bladder cancer	0.00255	0.00646	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—urinary bladder cancer	0.00244	0.00618	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—urinary bladder cancer	0.00243	1	CrCbGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—FGFR3—urinary bladder cancer	0.00242	0.00613	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—RB1—urinary bladder cancer	0.00242	0.00612	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDH1—urinary bladder cancer	0.00241	0.00609	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00233	0.00591	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00232	0.00586	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00224	0.00566	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.0022	0.00557	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LOXL1—urinary bladder cancer	0.00215	0.00543	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CREBBP—urinary bladder cancer	0.00214	0.00541	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—PLAU—urinary bladder cancer	0.00213	0.0054	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00212	0.00538	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN2A—urinary bladder cancer	0.00212	0.00538	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—urinary bladder cancer	0.00212	0.00537	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—ATM—urinary bladder cancer	0.00211	0.00534	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDK4—urinary bladder cancer	0.0021	0.00531	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—FGFR3—urinary bladder cancer	0.00207	0.00523	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—ERBB2—urinary bladder cancer	0.00203	0.00514	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC14A2—urinary bladder cancer	0.00195	0.00493	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CXCL8—urinary bladder cancer	0.00193	0.00487	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.00192	0.00487	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—urinary bladder cancer	0.00192	0.00485	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—urinary bladder cancer	0.00185	0.00469	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—urinary bladder cancer	0.00185	0.00469	CbGpPWpGaD
Doxycycline—CYP3A4—renal system—urinary bladder cancer	0.00185	0.00882	CbGeAlD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—urinary bladder cancer	0.00184	0.00467	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.00184	0.00465	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—RB1—urinary bladder cancer	0.00183	0.00462	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CCND1—urinary bladder cancer	0.00179	0.00454	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.00179	0.00453	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—urinary bladder cancer	0.00178	0.00451	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—urinary bladder cancer	0.00177	0.00448	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—IGF1—urinary bladder cancer	0.00174	0.0044	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN1A—urinary bladder cancer	0.00174	0.00439	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—urinary bladder cancer	0.00172	0.00436	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.0017	0.0043	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—urinary bladder cancer	0.0017	0.0043	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—RBX1—urinary bladder cancer	0.0017	0.00429	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—urinary bladder cancer	0.00167	0.00423	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—urinary bladder cancer	0.00163	0.00413	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—urinary bladder cancer	0.00156	0.00394	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—RHOA—urinary bladder cancer	0.00155	0.00393	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00153	0.00388	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—urinary bladder cancer	0.00151	0.00383	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—RHOA—urinary bladder cancer	0.0015	0.00379	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—urinary bladder cancer	0.00149	0.00378	CbGpPWpGaD
Doxycycline—CYP3A4—female reproductive system—urinary bladder cancer	0.00148	0.00707	CbGeAlD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—urinary bladder cancer	0.00148	0.00375	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—urinary bladder cancer	0.00148	0.00375	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—RHOA—urinary bladder cancer	0.00145	0.00366	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.00144	0.00365	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—urinary bladder cancer	0.00144	0.00365	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—urinary bladder cancer	0.00144	0.00364	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—EP300—urinary bladder cancer	0.00143	0.00363	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.00143	0.00362	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—urinary bladder cancer	0.00143	0.00362	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—PLAU—urinary bladder cancer	0.00142	0.00359	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—SRC—urinary bladder cancer	0.00142	0.00358	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—urinary bladder cancer	0.00141	0.00356	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00139	0.00352	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.00138	0.00349	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—urinary bladder cancer	0.00138	0.00348	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.00134	0.00339	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.00133	0.00337	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1A—urinary bladder cancer	0.00131	0.00332	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—PTEN—urinary bladder cancer	0.00131	0.00331	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.0013	0.00328	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—urinary bladder cancer	0.00126	0.0032	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—RHOA—urinary bladder cancer	0.00124	0.00315	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—urinary bladder cancer	0.00124	0.00314	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—urinary bladder cancer	0.00123	0.00312	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.00121	0.00307	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—urinary bladder cancer	0.00119	0.00301	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—urinary bladder cancer	0.00118	0.00299	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CREBBP—urinary bladder cancer	0.00117	0.00296	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—SRC—urinary bladder cancer	0.00115	0.00291	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—SRC—urinary bladder cancer	0.00114	0.00288	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—HRAS—urinary bladder cancer	0.00113	0.00286	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.00111	0.00282	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00111	0.0028	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—SRC—urinary bladder cancer	0.0011	0.00278	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—urinary bladder cancer	0.00109	0.00275	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.00106	0.00268	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—RHOA—urinary bladder cancer	0.00106	0.00268	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.00104	0.00264	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CDH1—urinary bladder cancer	0.00104	0.00262	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—urinary bladder cancer	0.00102	0.00257	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.001	0.00254	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—urinary bladder cancer	0.000997	0.00252	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—urinary bladder cancer	0.000996	0.00252	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—urinary bladder cancer	0.000982	0.00248	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TERT—urinary bladder cancer	0.000974	0.00247	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.000971	0.00246	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—urinary bladder cancer	0.000962	0.00243	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000959	0.00243	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—KRAS—urinary bladder cancer	0.000953	0.00241	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.000937	0.00237	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000935	0.00237	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—SRC—urinary bladder cancer	0.000911	0.00231	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.000908	0.0023	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000903	0.00228	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—urinary bladder cancer	0.000893	0.00226	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—SRC—urinary bladder cancer	0.000888	0.00225	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000885	0.00224	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000885	0.00224	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND1—urinary bladder cancer	0.000866	0.00219	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000861	0.00218	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—urinary bladder cancer	0.000847	0.00214	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000845	0.00214	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—HRAS—urinary bladder cancer	0.00081	0.00205	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000797	0.00202	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—EP300—urinary bladder cancer	0.000797	0.00202	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.000786	0.00199	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000783	0.00198	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ESR1—urinary bladder cancer	0.00078	0.00197	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—urinary bladder cancer	0.00078	0.00197	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CDH1—urinary bladder cancer	0.00077	0.00195	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CREBBP—urinary bladder cancer	0.000761	0.00193	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CDX2—urinary bladder cancer	0.00076	0.00192	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000759	0.00192	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.00075	0.0019	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—urinary bladder cancer	0.000749	0.0019	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000743	0.00188	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—KRAS—urinary bladder cancer	0.000736	0.00186	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000707	0.00179	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—urinary bladder cancer	0.000694	0.00176	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—RHOA—urinary bladder cancer	0.000688	0.00174	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000681	0.00172	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000678	0.00172	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000661	0.00167	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—urinary bladder cancer	0.000654	0.00165	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000653	0.00165	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—HRAS—urinary bladder cancer	0.000641	0.00162	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SRC—urinary bladder cancer	0.000634	0.00161	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HRAS—urinary bladder cancer	0.000625	0.00158	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000616	0.00156	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—urinary bladder cancer	0.00057	0.00144	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000569	0.00144	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CCND1—urinary bladder cancer	0.000563	0.00143	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000562	0.00142	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000557	0.00141	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CDKN1A—urinary bladder cancer	0.000545	0.00138	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000543	0.00137	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000543	0.00137	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000539	0.00136	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000536	0.00136	CbGpPWpGaD
Doxycycline—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000534	0.00135	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—KRAS—urinary bladder cancer	0.000525	0.00133	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—EP300—urinary bladder cancer	0.000518	0.00131	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000511	0.00129	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	0.000506	0.00128	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SRC—urinary bladder cancer	0.000504	0.00128	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	0.000488	0.00124	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000477	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	0.000465	0.00118	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—urinary bladder cancer	0.000452	0.00114	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00045	0.00114	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—HRAS—urinary bladder cancer	0.000447	0.00113	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IFNA2—urinary bladder cancer	0.000444	0.00112	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CDH1—urinary bladder cancer	0.000434	0.0011	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000417	0.00105	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000407	0.00103	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	0.000406	0.00103	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	0.000397	0.001	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000393	0.000994	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00039	0.000986	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	0.000375	0.000948	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—urinary bladder cancer	0.000371	0.000939	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000365	0.000923	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00036	0.00091	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000346	0.000875	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000346	0.000875	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000341	0.000863	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	0.000333	0.000843	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000325	0.000823	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000318	0.000804	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000316	0.0008	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAU—urinary bladder cancer	0.000315	0.000797	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—urinary bladder cancer	0.000314	0.000795	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000312	0.000789	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000285	0.000721	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000281	0.000712	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000281	0.000711	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000265	0.000671	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CREBBP—urinary bladder cancer	0.00026	0.000657	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IGF1—urinary bladder cancer	0.000257	0.000649	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000245	0.000621	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—RHOA—urinary bladder cancer	0.000235	0.000595	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000215	0.000543	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGF1—urinary bladder cancer	0.000202	0.000511	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL2—urinary bladder cancer	0.000197	0.000499	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000189	0.000479	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000187	0.000473	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000179	0.000453	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EP300—urinary bladder cancer	0.000177	0.000448	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SRC—urinary bladder cancer	0.000172	0.000435	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—urinary bladder cancer	0.000162	0.000411	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000151	0.000383	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000147	0.000372	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KRAS—urinary bladder cancer	0.000142	0.00036	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000132	0.000333	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—urinary bladder cancer	0.000127	0.00032	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HRAS—urinary bladder cancer	0.000121	0.000306	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000102	0.000258	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.0001	0.000254	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.0001	0.000254	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.36e-05	0.000237	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.23e-05	0.000234	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.38e-05	0.000212	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.24e-05	0.000158	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.91e-05	0.00015	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.91e-05	0.00015	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.41e-05	0.000137	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.87e-05	0.000123	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.6e-05	0.000116	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.48e-05	0.000113	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.58e-05	9.07e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.24e-05	8.2e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.8e-05	7.08e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.59e-05	6.55e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.59e-05	6.55e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.51e-05	6.36e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.09e-05	5.28e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	4.41e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.62e-05	4.1e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	4.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	4.05e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.53e-05	3.88e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	3.81e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	3.58e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.15e-05	2.9e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	2.79e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.02e-06	2.28e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.87e-06	1.99e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.5e-06	1.9e-05	CbGpPWpGaD
